Skip to main content
SpringerLink
Log in
Book cover

Focus on Extrapyramidal Dysfunction

  • Book
  • © 2004

Overview

Editors:
  1. Th. Müller

    1. Neurologische Klinik, St. Josef Hospital, Bochum, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. P. Riederer

    1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, 97080, Würzburg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • comprehensive presentation of basic and clinical research on extrapyramidal dysfunction • new therapeutic principles in extrapyramidal disorders • novel findings in Parkinson’s disease, Huntington’s disease and allied conditions

Part of the book series: Journal of Neural Transmission. Supplementa (NEURAL SUPPL, volume 68)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

  1. Front Matter

    Pages I-VIII
    Download chapter PDF

  2. Dopaminergic neurotoxicity of homocysteine and its derivatives in primary mesencephalic cultures

    • I. Heider, V. Lehmensiek, Th. Lenk, Th. Müller, A. Storch
    Pages 1-13

  3. MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson’s disease

    • D. Woitalla, W. Kuhn, T. Müller
    Pages 15-20

  4. Screening for mutations in synaptotagmin XI in Parkinson’s disease

    • A. S. Glass, D. P. Huynh, Th. Franck, D. Woitalla, Th. Müller, S. M. Pulst et al.
    Pages 21-28

  5. Depletion and restoration of endogenous monoamines affects β-CIT binding to serotonin but not dopamine transporters in non-human primates

    • A. Heinz, D.W. Jones, K. Zajicek, J. G. Gorey, G. Juckel, J. D. Higley et al.
    Pages 29-38

  6. Differential executive control impairments in early Parkinson’s disease

    • J. Uekermann, I. Daum, M. Bielawski, S. Muhlack, S. Peters, H. Przuntek et al.
    Pages 39-51

  7. Simple movement sequences better correlate to levodopa plasma levels than complex ones

    • S. Muhlack, S. Konietzka, D. Woitalla, H. Przuntek, Th. Müller
    Pages 53-60

  8. Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson’s disease

    • Ch Börnke, T. Schulte, H. Przuntek, Th. Müller
    Pages 61-67

  9. Impact of apomorphine on BOLD signal during movement in normals

    • G. Schmid, B. Suchan, J. Rusin, I. Daum, O. Köster, H. Przuntek et al.
    Pages 69-78

  10. Worsened motor test performance following acute apomorphine injection in previously untreated patients with Parkinson’s disease

    • Th. Müller, S. Benz, Ch. Börnke, S. Muhlack, D. Woitalla, H. Przuntek
    Pages 79-87

  11. Transdermal lisuride delivery in the treatment of Parkinson’s disease

    • D. Woitalla, T. Müller, S. Benz, R. Horowski, H. Przuntek
    Pages 89-95

  12. Congruent deterioration of complex and simple movements in patients with Huntington’s disease

    • C. Saft, J. Andrich, N.-M. Meisel, H. Przuntek, Th. Müller
    Pages 97-104

  13. Methyltetrahydrofolate reductase polymorphism influences onset of Huntington’s disease

    • N. Brune, J. Andrich, M. Gencik, C. Saft, Th. Müller, S. Valentin et al.
    Pages 105-110

  14. Coenzyme Q10 serum levels in Huntington’s disease

    • J. Andrich, C. Saft, M. Gerlach, B. Schneider, A. Arz, W. Kuhn et al.
    Pages 111-116

  15. The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease

    • A. Beister, P. Kraus, W. Kuhn, M. Dose, A. Weindl, M. Gerlach
    Pages 117-122

  16. Transcranial sonography in spinocerebellar ataxia type 3

    • Th. Postert, J. Eyding, D. Berg, H. Przuntek, G. Becker, M. Finger et al.
    Pages 123-133

  17. Therapeutic strategies in Friedreich’s ataxia

    • L. Schöls, Ch. Meyer, G. Schmid, I. Wilhelms, H. Przuntek
    Pages 135-145

  18. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder

    • V. G. Hösing, A. Schirmacher, G. Kuhlenbäumer, C. Freitag, P. Sand, C. Schlesiger et al.
    Pages 147-156
Back to top

Keywords

About this book

Experts in the fields of neurology, neuroscience, neurobiology and psychiatry review and present novel findings of basic and clinical research on extrapyramidal disorders and allied conditions. New insights on the nature of extrapyramidal dysfunction and its therapy in the fields of neurology, psychiatry and neuroscience are presented.

Editors and Affiliations

  • Neurologische Klinik, St. Josef Hospital, Bochum, Germany

    Th. Müller

  • Klinik und Poliklinik für Psychiatrie und Psychotherapie, 97080, Würzburg, Germany

    P. Riederer

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation